GDUFA Research Outcomes
Topical Products
This section contains scientific publications, presentations, and posters arising from GDUFA-funded research relevant to locally acting generic products administered via the topical route, including topical dermatological products.
-
Topical Semisolid Drug Product Critical Quality Attributes (Q3 Characterization) with Relevance to Topical Bioequivalence
Murthy, Narasimha
-
Characterizing Failure Modes And Critical Quality (Q3) Attributes Of Semi-Solid Topical Drug Products
Murthy, Narasimha
-
Evaluating Quality (Q3) Attributes And Potential Failure Modes For Topical Semisolid Drug Products
Murthy, Narasimha
-
Equivalence of Locally-Acting Drug Products
Luke, Markham
-
FDA’s Regulation of Drug Products Used by Dermatologists and Dermatologic Surgeons
Luke, Markham
-
History of Dermatology and Dermatologists at the U.S. Food and Drug Administration
Luke, Markham
-
FDA Science and Regulation for the Physician Scientist
Luke, Markham
-
FDA Update: FDA and Dermatologic DEIA
Luke, Markham
-
Innovation and Topical Generic Drug Science: A Case of Targeted and Planned Innovation
Luke, Markham
-
Generic Drugs and Dermatology: Bioequivalence and Access Equity
Luke, Markham